Hainan Huluwa Pharmaceutical Group Co., Ltd.
-
Founded in:
2005-06-22 -
Country:
China -
Address:
No. 8, Yaogu 4th Road, Phase II, Yaogu Industrial Park, Haikou National High-tech Zone, Haikou City, Hainan Province -
Tax NO.:
91460100774262258E -
Registered Funds:
400.108752 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Vidarabine monophosphate |
Extract from the above information
More
Extract from the above information |
29984-33-6 | 12 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Vidarabine monophosphate |
Extract from the above information
More
Extract from the above information |
29984-33-6 | 12 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Vidarabine monophosphate |
Extract from the above information
More
Extract from the above information |
29984-33-6 | 12 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| DL-Lysine acetylsalicylate |
Extract from the above information
More
Extract from the above information |
62952-06-1 | 13 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Tiopronin |
Animal experiments have shown that this product can reduce the increase of serum AST and ALT in the animal acute liver injury model caused by TAA (thioacetamide) and CC14 (carbon tetrachloride), and inhibit the accumulation of triglycerides caused by chronic liver injury model; it can promote liver glycogen synthesis, inhibit the increase of cholesterol, and help the recovery of serum albumin/globulin ratio.
More
Animal experiments have shown that this product can reduce the increase of serum AST and ALT in the animal acute liver injury model caused by TAA (thioacetamide) and CC14 (carbon tetrachloride), and inhibit the accumulation of triglycerides caused by chronic liver injury model; it can promote liver glycogen synthesis, inhibit the increase of cholesterol, and help the recovery of serum albumin/globulin ratio. |
1953-02-2 | 55 |